Open access
Sep 2026
A Myeloid-Specific Endogenous TRP1-CAR Knock-in Mouse Model for Melanoma-Targeted Immunotherapy
This myeloid-specific TRP1-CAR knock-in model shows in vitro antitumor activity and delayed melanoma progression in vivo, and provides a proof-of-concept framework for investigating antitumor activity and preliminary safety observations associated with sustained endogenous CAR expression.
Yu-Xin Hao, Xin Chen, Min Wang et al.
· ImmunoTargets and Therapy · 0 citations